Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen 72076, Germany.
Cell. 2020 Nov 25;183(5):1264-1281.e20. doi: 10.1016/j.cell.2020.09.054. Epub 2020 Oct 21.
The HLA-DR15 haplotype is the strongest genetic risk factor for multiple sclerosis (MS), but our understanding of how it contributes to MS is limited. Because autoreactive CD4 T cells and B cells as antigen-presenting cells are involved in MS pathogenesis, we characterized the immunopeptidomes of the two HLA-DR15 allomorphs DR2a and DR2b of human primary B cells and monocytes, thymus, and MS brain tissue. Self-peptides from HLA-DR molecules, particularly from DR2a and DR2b themselves, are abundant on B cells and thymic antigen-presenting cells. Furthermore, we identified autoreactive CD4 T cell clones that can cross-react with HLA-DR-derived self-peptides (HLA-DR-SPs), peptides from MS-associated foreign agents (Epstein-Barr virus and Akkermansia muciniphila), and autoantigens presented by DR2a and DR2b. Thus, both HLA-DR15 allomorphs jointly shape an autoreactive T cell repertoire by serving as antigen-presenting structures and epitope sources and by presenting the same foreign peptides and autoantigens to autoreactive CD4 T cells in MS.
HLA-DR15 单倍型是多发性硬化症 (MS) 的最强遗传风险因素,但我们对其如何导致 MS 的了解有限。由于自身反应性 CD4 T 细胞和 B 细胞作为抗原呈递细胞参与 MS 的发病机制,我们对人类原代 B 细胞和单核细胞、胸腺和 MS 脑组织中的两种 HLA-DR15 同种异型 DR2a 和 DR2b 的免疫肽组进行了表征。HLA-DR 分子的自身肽,特别是 DR2a 和 DR2b 本身的自身肽,在 B 细胞和胸腺抗原呈递细胞上丰富存在。此外,我们鉴定了能够与 HLA-DR 衍生的自身肽 (HLA-DR-SPs)、与 MS 相关的外来抗原 (EB 病毒和阿克曼氏菌粘液菌) 以及由 DR2a 和 DR2b 呈递的自身抗原发生交叉反应的自身反应性 CD4 T 细胞克隆。因此,两种 HLA-DR15 同种异型通过作为抗原呈递结构和表位来源,并通过将相同的外来肽和自身抗原呈递给 MS 中的自身反应性 CD4 T 细胞,共同塑造了自身反应性 T 细胞库。
Ann Neurol. 2025-8
Int J Environ Res Public Health. 2025-3-27
Neurol Neuroimmunol Neuroinflamm. 2020-3
Nat Rev Neurosci. 2019-11-11
Proc Natl Acad Sci U S A. 2019-8-2
Methods Mol Biol. 2019
J Autoimmun. 2019-5-16
Front Immunol. 2019-3-22
Nucleic Acids Res. 2019-1-8